Securus Medical Group, an Ohio-based medtech company, has raised $6.5m in series B financing.

The round was led by new investor 3X5 Special Opportunity Fund, and joined in participation by existing backers the University of Michigan and RiverVest Partners. Michigan made its investment through its Investment in New Technology Startups programme.

As part of the deal, Nicholas Walrod, principal of 3X5 Special Opportunity Fund, will join Securus’ board of directors.

The Cleveland-based firm also announced that medtech industry veteran, Steve…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?